The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living with Obesity

Protocol Name: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living with Obesity

Sponsor: Eli Lilly

Indication: CVD and CKD Outcomes in patients with Obesity

GFR: 21-75

Principal Investigator: Bernard Fischbach, MD

Location: Landry Center, 411 N. Washington Ave, Suite #6000, Dallas, TX 75246

DETAILS >